Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D W Hommer

Showing results (21-30 of 54) with videos related to

Pageof 6
Sort By:
Psychiatry Research|March 1, 1984
Prazosin, a specific alpha 1-noradrenergic receptor antagonist, has no effect on symptoms but increases autonomic arousal in schizophrenic patientsD W Hommer, T P Zahn, D Pickar, et al.
Advances in Biochemical Psychopharmacology|January 1, 1982
Effect of cholecystokinin of the activity of midbrain dopaminergic neuronsB S Bunney, A A Grace, D W Hommer, et al.
Journal of Autism and Developmental Disorders|August 1, 1994
Saccadic eye movements in normal children from 8 to 15 years of age: a developmental study of visuospatial attentionR G Ross, A D Radant, D A Young, et al.
Schizophrenia Research|May 1, 1994
Quantitative effects of typical and atypical neuroleptics on smooth pursuit eye tracking in schizophreniaR E Litman, D W Hommer, A Radant, et al.
Psychiatry Research|May 1, 1993
Personality and benzodiazepine sensitivity in anxious patients and control subjectsD S Cowley, P P Roy-Byrne, D J Greenblatt, et al.
Annals of the New York Academy of Sciences|January 1, 1985
The effects of cholecystokinin-like peptides in schizophrenics and normal human subjectsD W Hommer, D Pickar, J N Crawley, et al.
Archives of General Psychiatry|April 10, 1999
Hippocampal volume in patients with alcohol dependenceI Agartz, R Momenan, R R Rawlings, et al.
Psychopharmacology Series|January 1, 1987
Pharmacodynamic approaches to benzodiazepine action in manD W Hommer, V Matsuo, O M Wolkowitz, et al.
Archives of General Psychiatry|June 1, 1984
The effects of ceruletide in schizophreniaD W Hommer, D Pickar, A Roy, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|October 1, 1986
Cholecystokinin-dopamine coexistence: electrophysiological actions corresponding to cholecystokinin receptor subtypeD W Hommer, G Stoner, J N Crawley, et al.
Pageof 6

Showing results (21-30 of 54) with videos related to

Sort By:
Pageof 6
Psychiatry Research|March 1, 1984
Prazosin, a specific alpha 1-noradrenergic receptor antagonist, has no effect on symptoms but increases autonomic arousal in schizophrenic patientsD W Hommer, T P Zahn, D Pickar, et al.
Advances in Biochemical Psychopharmacology|January 1, 1982
Effect of cholecystokinin of the activity of midbrain dopaminergic neuronsB S Bunney, A A Grace, D W Hommer, et al.
Journal of Autism and Developmental Disorders|August 1, 1994
Saccadic eye movements in normal children from 8 to 15 years of age: a developmental study of visuospatial attentionR G Ross, A D Radant, D A Young, et al.
Schizophrenia Research|May 1, 1994
Quantitative effects of typical and atypical neuroleptics on smooth pursuit eye tracking in schizophreniaR E Litman, D W Hommer, A Radant, et al.
Psychiatry Research|May 1, 1993
Personality and benzodiazepine sensitivity in anxious patients and control subjectsD S Cowley, P P Roy-Byrne, D J Greenblatt, et al.
Annals of the New York Academy of Sciences|January 1, 1985
The effects of cholecystokinin-like peptides in schizophrenics and normal human subjectsD W Hommer, D Pickar, J N Crawley, et al.
Archives of General Psychiatry|April 10, 1999
Hippocampal volume in patients with alcohol dependenceI Agartz, R Momenan, R R Rawlings, et al.
Psychopharmacology Series|January 1, 1987
Pharmacodynamic approaches to benzodiazepine action in manD W Hommer, V Matsuo, O M Wolkowitz, et al.
Archives of General Psychiatry|June 1, 1984
The effects of ceruletide in schizophreniaD W Hommer, D Pickar, A Roy, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|October 1, 1986
Cholecystokinin-dopamine coexistence: electrophysiological actions corresponding to cholecystokinin receptor subtypeD W Hommer, G Stoner, J N Crawley, et al.
Pageof 6